Peptisource

Glow 70mg （Blend）

As a synthetic analog of Thymosin Beta-4 (Tβ4), TB4 is a polypeptide molecule with multiple biological activities. Its core mechanism of action is achieved by precisely regulating the dynamic balance between the polymerization and depolymerization of actin in the cytoskeleton. This molecule can significantly promote cell migration, proliferation, and differentiation, thereby playing a key regulatory role in the process of tissue repair and regeneration. In the repair of skin wounds, TB4 can accelerate wound closure, promote the orderly deposition of collagen, and inhibit the abnormal proliferation of pathological scar tissue. In the field of metabolic diseases, it alleviates inflammation-related pathological processes such as non-alcoholic fatty liver disease and pulmonary fibrosis by inhibiting the release of pro-inflammatory factors. In terms of cardiovascular protection, during the acute phase of myocardial infarction, TB4 can effectively protect surviving cardiomyocytes, activate the endogenous angiogenesis mechanism, optimize the myocardial microcirculation, and ultimately improve the cardiac pumping function. It is worth noting that TB4 exhibits high bioavailability, synergistic effects at multiple targets, and excellent biocompatibility. Its unique tissue-targeting property enables it to directly act on the microenvironment of damaged tissues. While achieving precise treatment, it significantly reduces the risk of systemic exposure, providing a theoretical basis and practical support for clinical applications.

Spec: Blend
Packaging: 1kits（10Vials）
$260USD
1

▎TB4


As a synthetic analog of Thymosin Beta-4 (Tβ4), TB4 is a polypeptide molecule with multiple biological activities. Its core mechanism of action is achieved by precisely regulating the dynamic balance between the polymerization and depolymerization of actin in the cytoskeleton. This molecule can significantly promote cell migration, proliferation, and differentiation, thereby playing a key regulatory role in the process of tissue repair and regeneration. In the repair of skin wounds, TB4 can accelerate wound closure, promote the orderly deposition of collagen, and inhibit the abnormal proliferation of pathological scar tissue. In the field of metabolic diseases, it alleviates inflammation-related pathological processes such as non-alcoholic fatty liver disease and pulmonary fibrosis by inhibiting the release of pro-inflammatory factors. In terms of cardiovascular protection, during the acute phase of myocardial infarction, TB4 can effectively protect surviving cardiomyocytes, activate the endogenous angiogenesis mechanism, optimize the myocardial microcirculation, and ultimately improve the cardiac pumping function. It is worth noting that TB4 exhibits high bioavailability, synergistic effects at multiple targets, and excellent biocompatibility. Its unique tissue-targeting property enables it to directly act on the microenvironment of damaged tissues. While achieving precise treatment, it significantly reduces the risk of systemic exposure, providing a theoretical basis and practical support for clinical applications.